Recent developments in oncology have led to a better molecular and cellular understanding
of cancer, and the introduction of novel therapies. Conjunctival melanoma (CoM) is a rare …

Conjunctival melanoma is a rare but sight and life threatening malignancy. It accounts for
2%–5% of all ocular tumours and 5%–7% of all ocular melanomas with an incidence of 0.2 …

Background Dynamic N 6-methyladenosine (m 6 A) RNA modification generated and
erased by N 6-methyltransferases and demethylases regulates gene expression, alternative …

Purpose To investigate incidence, clinicopathological features and prognosis of BRAF‐
mutated conjunctival melanoma in Denmark. Furthermore, to determine BRAF mutations in …

Abstract Background and Objective The purpose of the present study was to investigate low-
shot deep learning models applied to conjunctival melanoma detection using a small …

Background Herein, we describe the use of systemic immunotherapy for both locally
advanced and metastatic conjunctival melanoma. Current treatments for advanced …

Conjunctival melanoma is a rare tumor of the conjunctival epithelium with a heterogenous
clinical presentation and a propensity for regional and distant metastatic spread. Guidelines …

The ruthenium-based photosensitizer (PS) TLD1433 has completed a phase I clinical trial
for photodynamic therapy (PDT) treatment of bladder cancer. Here, we investigated a …

Conjunctival malignant melanoma is a rare disease associated with considerable mortality.
Most published data have been based on case reports or series of referred patients. In …

Simple Summary Conjunctival melanoma (Co-M) is a rare and aggressive eye surface
cancer. It is often misdiagnosed or overlooked, leading to late diagnosis. Co-M can cause …